A Randomized, Placebo-controlled, Double-blind Trial of Multiple Ascending Doses of ZP4207 Administered to Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP4207

Trial Profile

A Randomized, Placebo-controlled, Double-blind Trial of Multiple Ascending Doses of ZP4207 Administered to Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP4207

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Nov 2015

At a glance

  • Drugs Dasiglucagon (Primary)
  • Indications Hypoglycaemia
  • Focus Adverse reactions
  • Sponsors Zealand Pharma
  • Most Recent Events

    • 26 Jun 2015 According to a Zealand Pharma media release, results of this study are expected in H2 2015.
    • 26 Jun 2015 Status changed from recruiting to completed, according to a Zealand Pharma media release.
    • 20 May 2015 Results are expected in the second half of 2015, according to a Zealand Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top